Nintendo Wii Virtual Reality Application In Dementia

Sponsor
Kırıkkale University (Other)
Overall Status
Completed
CT.gov ID
NCT04819126
Collaborator
(none)
32
1
2
12
2.7

Study Details

Study Description

Brief Summary

•This study was planned to investigate the effects of the Nintendo Wii virtual reality application on muscle strength and fall risk in individuals with AD.

The aim of the present study is to investigate the effect of the virtual reality application on muscle strength and fall in individuals with Alzheimer' Dementia (AD).

Condition or Disease Intervention/Treatment Phase
  • Other: Nintendo Wii Virtual Reality Application
N/A

Detailed Description

Purpose: This study was planned to investigate the effects of the Nintendo Wii virtual reality application on muscle strength and fall risk in individuals with AD.

Method: The study included a total of 32 volunteers between the ages of 65-80, with mild or moderate AD diagnosed. These individuals were divided into 2 groups as a training group and control group. The training group was trained with games from different categories such as balance and aerobic exercises with a Nintendo Wii virtual reality device 2 times a week for a period of 6 weeks, with 1 session lasting for 30 minutes. Mini-Mental State Test, Knee Extension Muscle Strength, Timed Up and Go Test, Tinetti Falls Efficacy Scale results of individuals were recorded in the evaluation.

Study Design

Study Type:
Interventional
Actual Enrollment :
32 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Treatment
Official Title:
Nintendo Wii Virtual Reality Application In Older People With Alzheimer's Dementia
Actual Study Start Date :
Jan 15, 2018
Actual Primary Completion Date :
Jun 6, 2018
Actual Study Completion Date :
Jan 15, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: Nintendo Wii Virtual Reality Application In Older People With Alzheimer's Dementia

The study included a total of 32 volunteers between the ages of 65-80, who stayed in Karaman Ahmet Mete Nursing Home, Elderly Care and Rehabilitation Center, with mild or moderate Alzheimer's dementia diagnosed by a neurologist. As a result of the power analysis, it was calculated that at least 16 individuals could be included in each group (at least 32 individuals in total). Randomization was performed by the sealed-envelope method. According to this method, 4 females and 12 males were determined to be in the control group, while 5 females and 11 males were determined to be in the training group. The evaluation was completed before the intervention. The same evaluation was conducted after 6 weeks. The training group was trained with games from different categories such as balance and aerobic exercises with a Nintendo Wii virtual reality device 2 times a week for a period of 6 weeks, with 1 session lasting for 30 minutes, and each patient was trained with the same games.

Other: Nintendo Wii Virtual Reality Application
The training group was trained with games from different categories such as balance and aerobic exercises with a Nintendo Wii virtual reality device 2 times a week for a period of 6 weeks, with 1 session lasting for 30 minutes.

No Intervention: Older People With Alzheimer's Dementia

In the control group, no application was performed during this period, and routine medical treatments were continued. The training group was evaluated before and after the training, while the control group was re-evaluated at the end of the 6th week after the first evaluation. After the study was completed, the volunteers from the control group were also given training.

Outcome Measures

Primary Outcome Measures

  1. Age :mean or median age [period of 6 weeks]

    Age, Categorical: >=65 years

  2. Body Mass Index [period of 6 weeks]

    BMI was recorded in kg/m^2.

  3. Sex/Gender [period of 6 weeks]

    Sex: Female, Male

Secondary Outcome Measures

  1. The Mini-Mental State Test for Cognitive status [period of 6 weeks]

    According to the MMST, 24-30 points were considered as normal cognitive levels, 18-23 points were considered as mild cognitive disorders, and 0-17 points were considered as severe cognitive disorders

Eligibility Criteria

Criteria

Ages Eligible for Study:
65 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • included volunteers between the ages of 65-80 with mild or moderate AD diagnosis,

  • who did not have any difficulty or problems in communicating,

  • who did not have any neurological diseases that disrupt balance and coordination such as a cerebrovascular event, Parkinson's disease, Multiple Sclerosis, and neurological disorder,

  • who obtained a score of 18 - 24 points in the Mini-Mental State Test (MMST)

Exclusion Criteria:
  • Patients diagnosed with rapidly progressing dementia (infection, vascular, hematologic diseases),

  • Those who could not be contacted during the follow-up period or who did not participate in the training session, those who experienced cardiac and cerebrovascular events, endocrine disorders, fluid-electrolyte imbalance and infection,

  • Those with malignancy and those who received chemotherapy and radiotherapy that causes malignancy, delirium or depression and malignant sensory loss (those with the Semmes-Weinstein monofilament thickness of 4.56 and above),

  • Those with a lower or upper extremity amputation at any level

Contacts and Locations

Locations

Site City State Country Postal Code
1 Karaman Ahmet Mete Nursing Home Konya Turkey

Sponsors and Collaborators

  • Kırıkkale University

Investigators

  • Principal Investigator: Konya Karaman Ahmet Mete Nursing Home, Karaman Ahmet Mete Nursing Home. Konya in Turkey

Study Documents (Full-Text)

More Information

Publications

None provided.
Responsible Party:
Meral SERTEL, Kırıkkale University, Kırıkkale University
ClinicalTrials.gov Identifier:
NCT04819126
Other Study ID Numbers:
  • Karamanoğlu Mehmet Bey U
  • Kırıkkale University
First Posted:
Mar 26, 2021
Last Update Posted:
Mar 26, 2021
Last Verified:
Mar 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
No
Keywords provided by Meral SERTEL, Kırıkkale University, Kırıkkale University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 26, 2021